Featured news
All news
Showing 20 results
Cambridge Professor receives OBE for services to cancer
Professor Rebecca Fitzgerald, director of the Early Cancer Institute, has received an Officer of the Order of the British Empire (OBE) for services to cancer.
Blood cancer manipulates immune cells to survive
The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive.
High risk surgery on teen testicular cancer patient
Surgeons at Addenbrooke’s Hospital in Cambridge undertake some of the most complex operations in the country –– and at 9pm on BBC Two on Wednesday (8 Feb) this includes high-risk surgery on a teenager, following treatment for testicular cancer.
Planning permission submitted for East of England cancer hospital
A full planning application to build a new specialist cancer research hospital for the region on the Cambridge Biomedical Campus has been submitted to Cambridge City Council.
Major funding for Cambridge to find cancer treatments
Around £3 million has been awarded to Cambridge doctors and scientists to boost research in to new cancer treatments, including vital trials involving Addenbrooke's patients.
First UK proton beam therapy trial for breast cancer
A UK trial is underway to test the benefits of proton beam therapy for certain patients with breast cancer, led by Professor Charlotte Coles, an oncology consultant at Addenbrooke’s Hospital.
Technique to prevent relapse in breast cancer patients
Cambridge scientists have managed to identify and kill breast cancer cells that evade standard treatments in a new study.
Online platform to check for prostate cancer risk
Cambridge scientists have created an online tool for predicting an individual’s risk of developing prostate cancer, to enable more targeted testing, treatment and early diagnosis.
New hope for kidney cancer treatment
Cambridge researchers have discovered that a drug used to treat lung cancer could potentially help patients with a type of kidney cancer called renal cell carcinoma.
Cancer patients to help trial ‘life saving’ home testing kit
Addenbrooke’s hospital is helping to trial a new home-testing device to check if cancer patients are at risk from a serious side effect of chemotherapy.
Making prostate cancer diagnosis simple, safe and affordable
A new medical device developed at Addenbrooke's hopes to transform the process of diagnosing prostate cancer, making it safer for patients.
Cancer research could have 'far-reaching' implications
The research lead for Cambridge Cancer Research Hospital says new findings to come out of his lab are the most important in three decades.
Genetic test rules out cancer for baby Oliver
A baby who was born with a large tumour on his leg has been spared chemotherapy and surgery, after whole genome sequencing at Addenbrooke’s revealed the lump was harmless.
Patients help to improve radiotherapy services
A new multimedia display at Addenbrooke’s highlights how patients have helped shape radiotherapy treatment.
Launch of UK's first institute for early cancer research
The Early Cancer Institute opens today next door to Addenbrooke's, to help create a world where we can detect cancer early enough to cure it.
MPs pledge support for regional Cancer Research Hospital
Nurse Debbie’s pedal push follows brave cancer journey
An Addenbrooke’s cancer nurse and keen cyclist has come through the most complicated ride of her life.
New regional cancer hospital one step closer
The Cambridge Cancer Research Hospital (CCRH) project has been given the green light by the government’s New Hospital Programme to commence the process that will lead to the appointment of a construction partner.
New clues to treat germ cell tumours
A study by a team from Addenbrooke’s and the Wellcome Sanger Institute has revealed more about the origin of germ cell tumours, usually found in the ovaries and testicles, suggesting new approaches to future treatment.
Home in a day after robotic cancer surgery
A surgical robot at Addenbrooke’s is helping to cure patients with prostate cancer, enabling them to go home less than 24 hours after surgery.